Arzu Onar

1.1k total citations
25 papers, 806 citations indexed

About

Arzu Onar is a scholar working on Genetics, Neurology and Electrical and Electronic Engineering. According to data from OpenAlex, Arzu Onar has authored 25 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 5 papers in Neurology and 5 papers in Electrical and Electronic Engineering. Recurrent topics in Arzu Onar's work include Glioma Diagnosis and Treatment (12 papers), Neuroblastoma Research and Treatments (5 papers) and Probabilistic and Robust Engineering Design (5 papers). Arzu Onar is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Neuroblastoma Research and Treatments (5 papers) and Probabilistic and Robust Engineering Design (5 papers). Arzu Onar collaborates with scholars based in United States, Sweden and South Africa. Arzu Onar's co-authors include Shihab Asfour, Sohyung Cho, W. J. Padgett, James M. Boyett, Mehmet Koçak, Ian F. Pollack, Roger J. Packer, Raja B. Khan, Stewart Goldman and Peter C. Burger and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and BMC Bioinformatics.

In The Last Decade

Arzu Onar

25 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arzu Onar United States	14	231	207	199	131	103	25	806
Bingkun Chen China	18	20 0.1×	21 0.1×	176 0.9×	88 0.7×	13 0.1×	38	834
Bertil Jönsson Sweden	18	29 0.1×	210 1.0×	187 0.9×	7 0.1×	16 0.2×	53	978
Chun‐Yang Fan United States	22	30 0.1×	91 0.4×	675 3.4×	27 0.2×	39 0.4×	70	1.4k
Pavel Procházka Czechia	12	76 0.3×	56 0.3×	208 1.0×	50 0.4×	43 0.4×	59	572
Kyoungmin Lee South Korea	13	66 0.3×	20 0.1×	144 0.7×	34 0.3×	80 0.8×	70	813
Toshikage Nagao Japan	14	70 0.3×	158 0.8×	173 0.9×	38 0.3×	29 0.3×	53	558
Yoichi Nonaka Japan	19	35 0.2×	27 0.1×	46 0.2×	48 0.4×	342 3.3×	61	845
Jue Hu China	13	50 0.2×	35 0.2×	168 0.8×	31 0.2×	13 0.1×	44	524
Congjun Wang China	21	16 0.1×	135 0.7×	284 1.4×	61 0.5×	10 0.1×	78	1.1k
Yunlei Li Netherlands	16	15 0.1×	78 0.4×	236 1.2×	49 0.4×	11 0.1×	46	732

Countries citing papers authored by Arzu Onar

Since Specialization

Citations

This map shows the geographic impact of Arzu Onar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arzu Onar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arzu Onar more than expected).

Fields of papers citing papers by Arzu Onar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arzu Onar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arzu Onar. The network helps show where Arzu Onar may publish in the future.

Co-authorship network of co-authors of Arzu Onar

This figure shows the co-authorship network connecting the top 25 collaborators of Arzu Onar. A scholar is included among the top collaborators of Arzu Onar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arzu Onar. Arzu Onar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Kyle, Catherine A. Billups, Sandeep Kumar Dhanda, et al.. (2022). MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy. Neuro-Oncology. 24(Supplement_1). i122–i122. 1 indexed citations

Margol, Ashley, Kee Kiat Yeo, Caihong Xia, et al.. (2018). A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children’s Oncology Group. Journal of Neuro-Oncology. 140(3). 575–582. 9 indexed citations

Murphy, Erin S., Jason Fangusaro, Girish Dhall, et al.. (2018). A Phase 2 Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT): A Children’s Oncology Group (COG) Study. Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors. International Journal of Radiation Oncology*Biology*Physics. 102(3). S49–S50. 2 indexed citations

Hwang, Eugene, Arzu Onar, Duane A. Mitchell, et al.. (2018). IMMU-09. OUTCOME OF PATIENTS WITH RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) TREATED WITH PEMBROLIZUMAB (ANTI-PD-1): A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC045). Neuro-Oncology. 20(suppl_2). i100–i100. 14 indexed citations

Lulla, Rishi, Stewart Goldman, Tohru Yamada, et al.. (2016). Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study. Neuro-Oncology. 18(9). 1319–1325. 117 indexed citations

Jakacki, Regina I., Peter C. Burger, Tianni Zhou, et al.. (2012). Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study. Journal of Clinical Oncology. 30(21). 2648–2653. 131 indexed citations

Crom, Deborah B., Daniel Smith, Arzu Onar, et al.. (2010). Health Status in Long-Term Survivors of Pediatric Craniopharyngiomas. Journal of Neuroscience Nursing. 42(6). 323–328. 47 indexed citations

Onar, Arzu, Mehmet Koçak, & James M. Boyett. (2009). Continual Reassessment Method vs. Traditional Empirically Based Design: Modifications Motivated by Phase I Trials in Pediatric Oncology by the Pediatric Brain Tumor Consortium. Journal of Biopharmaceutical Statistics. 19(3). 437–455. 33 indexed citations

Onar, Arzu, Uma Ramamurthy, Dana Wallace, & James M. Boyett. (2009). An Operational Perspective of Challenging Statistical Dogma While Establishing a Modern, Secure Distributed Data Management and Imaging Transport System: The Pediatric Brain Tumor Consortium Phase I Experience. Clinical and Translational Science. 2(2). 143–149. 3 indexed citations

10.

Asfour, Shihab, et al.. (2009). Tin Whisker Electrical Short Circuit Characteristics—Part II. IEEE Transactions on Electronics Packaging Manufacturing. 32(1). 41–48. 10 indexed citations

11.

Sanders, Robert P., Arzu Onar, James M. Boyett, et al.. (2008). M1 Medulloblastoma: high risk at any age. Journal of Neuro-Oncology. 90(3). 351–355. 18 indexed citations

12.

Pounds, Stanley, Cheng Cheng, Wenjian Yang, et al.. (2008). A permutation-based method to identify loss-of-heterozygosity using paired genotype microarray data. BMC Bioinformatics. 9(S7). 8 indexed citations

13.

Onar, Arzu, et al.. (2007). Bayesian Degradation Modeling in Accelerated Pavement Testing with Estimated Transformation Parameter for the Response. Journal of Transportation Engineering. 133(12). 677–687. 5 indexed citations

14.

Chakraborty, Pinaki, Shihab Asfour, Sohyung Cho, Arzu Onar, & Matthew Lynn. (2007). Modeling tool wear progression by using mixed effects modeling technique when end-milling AISI 4340 steel. Journal of Materials Processing Technology. 205(1-3). 190–202. 23 indexed citations

15.

Kieran, Mark W., Roger J. Packer, Arzu Onar, et al.. (2007). Phase I and Pharmacokinetic Study of the Oral Farnesyltransferase Inhibitor Lonafarnib Administered Twice Daily to Pediatric Patients With Advanced Central Nervous System Tumors Using a Modified Continuous Reassessment Method: A Pediatric Brain Tumor Consortium Study. Journal of Clinical Oncology. 25(21). 3137–3143. 46 indexed citations

16.

Khan, Raja B., Frederick A. Boop, Arzu Onar, & Robert A. Sanford. (2006). Seizures in children with low-grade tumors: outcome after tumor resection and risk factors for uncontrolled seizures. Journal of Neurosurgery Pediatrics. 104(6). 377–382. 21 indexed citations

17.

Onar, Arzu, et al.. (2006). Statistical Mixed Effects Models for Evaluation and Prediction of Accelerated Pavement Testing Results. Journal of Transportation Engineering. 132(10). 771–780. 9 indexed citations

18.

Khan, Raja B. & Arzu Onar. (2006). Seizure Recurrence and Risk Factors after Antiepilepsy Drug Withdrawal in Children with Brain Tumors. Epilepsia. 47(2). 375–379. 28 indexed citations

19.

Cho, Sohyung, et al.. (2004). Tool breakage detection using support vector machine learning in a milling process. International Journal of Machine Tools and Manufacture. 45(3). 241–249. 154 indexed citations

20.

Onar, Arzu & W. J. Padgett. (2000). Accelerated test models with the inverse Gaussian distribution. Journal of Statistical Planning and Inference. 89(1-2). 119–133. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact